Retraction Note: BMC Complement Altern Med 15, 201 (2015)
https://doi.org/10.1186/s12906-015-0733-1
The Editor has retracted this article. After publication, concerns were raised regarding western blot image similarities between Fig. 3B in this article and Fig. 3C in another article with one shared author [1] that was under consideration within a close time frame.
Additionally, the JNK blots in Fig. 3B are presented upside-down, and there appear to be unexplained breaks in the western blot backgrounds in Fig. 4B.
The authors have been unable to provide the original blots from the experiments reported in this article. The Editor therefore no longer has confidence in the presented data.
Author Zhuoan Cheng agrees to this retraction. Author Cheng Liu has not explicitly stated whether they agree to this retraction notice. Authors Xia Yuan, Le Tao, Zhuoan Cheng, Xiuqin Dai, Xia Sheng and Dongying Xue have not responded to any correspondence from the editor or publisher about this retraction.
Reference
Liu C, Yang Z, Wang L, et al. Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats. BMC Gastroenterol. 2015;15:159. https://doi.org/10.1186/s12876-015-0380-5.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Liu, C., Yuan, X., Tao, L. et al. Retraction Note: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways. BMC Complement Med Ther 22, 236 (2022). https://doi.org/10.1186/s12906-022-03714-x
Published:
DOI: https://doi.org/10.1186/s12906-022-03714-x